Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10851| Title: | Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder. | Austin Authors: | Judd, F K;Chua, P;Lynch, C;Norman, Trevor R | Affiliation: | University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Vic. | Issue Date: | 1-Sep-1991 | Publication information: | The Australian and New Zealand Journal of Psychiatry; 25(3): 412-4 | Abstract: | Recently, much research interest has been directed to demonstrating a possible biological basis to obsessive compulsive disorder. In particular, dysregulation in brain serotonin is suggested to be important. Two cases are described in which fenfluramine, a presynaptic 5 HT-releasing agent and 5HT-reuptake inhibitor was used to augment clomipramine treatment for OCD. | Gov't Doc #: | 1958165 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/10851 | Journal: | The Australian and New Zealand Journal of Psychiatry | URL: | https://pubmed.ncbi.nlm.nih.gov/1958165 | Type: | Journal Article | Subjects: | Adult Clomipramine.administration & dosage Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Female Fenfluramine.administration & dosage Humans Obsessive-Compulsive Disorder.psychology.therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.